The effect of anti-alphaGal antibody removal with immunoabsorption and splenectomy on CD46 transgenic kidney xenograft survival.
Dean
P G
PG
Division of Transplantation Surgery, Mayo Foundation and Clinic, Rochester, Minnesota, USA.
Cohen
A J
AJ
Dalla Valle
H
H
Grande
J P
JP
Diamond
L E
LE
Byrne
G W
GW
Logan
J S
JS
McGregor
C G
CG
Stegall
M D
MD
D000818:Animals; D000906:Antibodies / Q000276:immunology*; D015703:Antigens, CD / Q000276:immunology*; D003176:Complement C3 / Q000378:metabolism; D004187:Disaccharides / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology* / Q000502:physiology; D007075:Immunoglobulin M / Q000378:metabolism; D007163:Immunosorbent Techniques; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000276:immunology*; D010215:Papio; D013156:Splenectomy; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
D000906:Antibodies; D015703:Antigens, CD; D003176:Complement C3; D004187:Disaccharides; D007075:Immunoglobulin M; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; C055075:galactosyl-(1-3)galactose